DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results. The findings — presented at American Head & Neck ...
February 14, 2008 — Patients with head and neck cancer positive for human papillomavirus (HPV) have a better response to chemotherapy and chemoradiation and better overall survival than patients with ...
Please provide your email address to receive an email when new articles are posted on . A triple-therapy combination extended OS compared with historical data among certain patients with advanced ...
In human papillomavirus (HPV)-based screening, a repeat HPV test is often recommended for HPV-positive women with normal cytology (HPV-pos/cyt-neg), but its absolute risk of cervical precancer (CIN3+) ...
PDS0101, an innovative immunotherapy, targets HPV-positive cancers, including recurrent or metastatic head and neck cancer with high-risk HPV16 infection. VERSATILE-002 Phase 2 clinical trial ...
A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma. Economic ...
Researchers at the University of Texas MD Anderson Cancer Center, in Houston, have shown that the current staging system for human papilloma virus (HPV)–positive oropharyngeal cancer is not adequate.
PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotechnology company focusing on innovative protein-based vaccines, and Gustave Roussy, the leading cancer centre in Europe ranked third Best ...
HOUSTON - Oropharyngeal cancer patients whose tumors in the upper part of the throat test positively for the human papillomavirus (HPV) have better overall survival than patients with HPV-negative ...
A new research paper was published in Volume 16 of Genes & Cancer on August 6, 2025, titled "Epstein-Barr virus nuclear antigen 1 upregulates Derlin1 and PSMD10 expression in HeLa cells." In this ...
Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show noninferiority versus standard care, which "reset the bar" for future trials of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback